GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 2 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,048,000 | +116.7% | 103,490 | +1.6% | 0.02% | +114.3% |
| Q2 2022 | $3,252,000 | +38.8% | 101,811 | +27.2% | 0.01% | +75.0% |
| Q4 2021 | $2,343,000 | +213.7% | 80,042 | +173.1% | 0.00% | +33.3% |
| Q3 2021 | $747,000 | -89.9% | 29,307 | -78.1% | 0.00% | -93.6% |
| Q3 2020 | $7,382,000 | -47.3% | 133,872 | -39.6% | 0.05% | -52.0% |
| Q2 2020 | $14,001,000 | +33.8% | 221,786 | -69.4% | 0.10% | +42.0% |
| Q4 2016 | $10,462,000 | – | 724,024 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |